Salmeterol xinafoate / fluticasone propionate
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Salmeterol xinafoate / fluticasone propionate, covering 2010-06-24 to 2026-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. [Phase 3]